Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Ondansetron Injection, USP 4mg/2mL

Ondansetron Injection is a 5-HT3 receptor antagonist indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy and for postoperative nausea and/or vomiting.